Clinical trial
TYSABRI Global Observational Program in Safety
NCT00477113 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00477113 |
|---|---|
| Title | TYSABRI Global Observational Program in Safety |
| Official title | TYGRIS: TYSABRI® Global Observational Program in Safety |
| Acronym | TYGRIS |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 2,207 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2015 |
| Completion | May 1, 2015 |
| First posted | May 22, 2007 |
| Last update posted | Jun 22, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: